Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search


Photonz’s Chief Scientific Officer Wins NZBIO Award

Photonz’s Chief Scientific Officer Wins NZBIO Award

Dr Hywel Griffiths, Chief Scientific Officer for Photonz Corp. was named the 2013 Young Biotechnologist of the Year by NZBIO at an award ceremony Tuesday evening.

The award is presented to an individual under the age of 40 whose work demonstrates the potential for future leadership in New Zealand’s bioeconomy.

Dr Griffiths won in recognition of his work at Photonz in the development of non-fish eicosapentanoic acid (EPA) produced directly by algal fermentation.

EPA is an increasingly valued ingredient used in the health and pharmaceutical industries. Photonz’s EPA is set to be the first viable replacement source for EPA which otherwise can only be extracted from already-at-risk global fish stocks. Dr Griffiths believes in the positive impact on human and animal health that this product can bring, as well as the environmental advantages of production by fermentation rather than extraction from fish resources.

“Dr Griffiths has made impressive contributions to the New Zealand bio-science community,” said Dr Greg Collier, CEO, Photonz Corp. “Working in the commercial setting of an early stage biotechnology enterprise is challenging enough. But to demonstrate leadership, determination, and remain passionate in his efforts to deliver an ecologically and socially responsible end product, over a seven year span, has amazed us all.”

“I’m honoured to receive this award, and I’m extremely grateful to the talented team at Photonz whose hard work and dedication has supported all the progress that we’ve made,” said Dr Griffiths.


About Photonz: Founded in New Zealand in 2002, Photonz Corporation produces the omega-3 fatty acid eicosapentaenoic acid (EPA) which is a critical ingredient in novel therapeutics for the cardiovascular disease market. Photonz has proprietary control over a unique fermentation process involving an EPA-rich strain of marine microalgae. This has been shown to produce EPA in a range of purities up to 97% and to be suited to pharmaceutical applications. Photonz is approaching a commercial-ready phase with facilities in the UK and France involved in late-stage up-scaling of an already proven manufacturing process. EPA, which has a range of food-based and therapeutic applications, is otherwise derived from fish oil.

© Scoop Media

Business Headlines | Sci-Tech Headlines


Land & Water Forum: Fourth Report On Water Management

The Land and Water Forum (LWF) today published its fourth report, outlining 60 new consensus recommendations for how New Zealand should improve its management of fresh water and calling on the Government to urgently adopt all of its recommendations from earlier reports. More>>



Welcome Home: Record High Migration Stokes 41-Year High Population Growth

New Zealand annual net migration hit a new high in October as more people arrived from than departed for Australia for the first time in more than 20 years. More>>


Citizens' Advice Bureau: Report Shows Desperate Housing Situation Throughout NZ

CAB's in-depth analysis of over 2000 client enquiries about emergency accommodation shows vulnerable families, pregnant women and children living in cars and garages, even after seeking assistance from the Ministry of Social Development and Housing New Zealand. More>>


Speaking For The Bees: Greens Call For Neonicotinoid Pesticide Ban

The National Government should ban the use of controversial pesticides called neonicotinoids after evidence has revealed that even at low doses they cause harm to bee populations, the Green Party said today. More>>


Get More From Scoop

Search Scoop  
Powered by Vodafone
NZ independent news